Thomas Denize
Harvard University(US)Massachusetts General Hospital(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Cancer Diagnosis and Treatment, Systemic Sclerosis and Related Diseases, Renal and related cancers
Most-Cited Works
- → Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma(2021)602 cited
- → Progressive immune dysfunction with advancing disease stage in renal cell carcinoma(2021)492 cited
- → A pathology foundation model for cancer diagnosis and prognosis prediction(2024)348 cited
- → Integrative clinical and molecular characterization of translocation renal cell carcinoma(2022)112 cited
- → Development of a Histopathology Informatics Pipeline for Classification and Prediction of Clinical Outcomes in Subtypes of Renal Cell Carcinoma(2021)89 cited
- → Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians(2018)69 cited
- → KDM6A epigenetically regulates subtype plasticity in small cell lung cancer(2023)61 cited
- → Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1(2022)39 cited
- → Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas(2018)36 cited
- → Epigenomic charting and functional annotation of risk loci in renal cell carcinoma(2023)33 cited